TIM
Thornburg Investment Management Portfolio holdings
AUM
$7.77B
1-Year Return
28.65%
This Quarter Return
+1.65%
1 Year Return
+28.65%
3 Year Return
+99.26%
5 Year Return
+176.66%
10 Year Return
+307.84%
AUM
$71.5B
AUM Growth
+$64B
(+845%)
Cap. Flow
-$2.98B
Cap. Flow
% of AUM
-4.17%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
197
New
9
Increased
29
Reduced
135
Closed
15
Top Buys
| 1 |
Merck
MRK
|
$1.09B |
| 2 |
MRX
Marex Group
MRX
|
$243M |
| 3 |
Alcon
ALC
|
$237M |
| 4 |
SOBO
South Bow Corporation
SOBO
|
$197M |
| 5 |
Freeport-McMoran
FCX
|
$153M |
Top Sells
| 1 |
AbbVie
ABBV
|
$1.02B |
| 2 |
CME Group
CME
|
$690M |
| 3 |
Broadcom
AVGO
|
$253M |
| 4 |
Kanzhun
BZ
|
$247M |
| 5 |
Equitable Holdings
EQH
|
$215M |
Sector Composition
| 1 | Financials | 25.3% |
| 2 | Healthcare | 15.21% |
| 3 | Technology | 15.07% |
| 4 | Communication Services | 14.09% |
| 5 | Consumer Discretionary | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
HDFC Bank
HDB
$361B
| $28.1M | 0.04% |
42,353
-15,065
| -26% | -$10M |
|
152
iShares MSCI EAFE ETF
EFA
$66.2B
| $25.7M | 0.04% |
31,385
-182,597
| -85% | -$149M |
|
153
Hyatt Hotels
H
$13.8B
| $25M | 0.03% |
20,407
-6,787
| -25% | -$8.31M |
|
154
Bristol-Myers Squibb
BMY
$96B
| $23.4M | 0.03% |
38,400
| – | – |
|
|
NBIS
155
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.6B
| $21.9M | 0.03% |
+103,823
| New | +$21.9M |
|
156
Amazon
AMZN
$2.48T
| $21.7M | 0.03% |
11,396
-677
| -6% | -$1.29M |
|
157
Syndax Pharmaceuticals
SNDX
$1.47B
| $16.1M | 0.02% |
130,746
+15,659
| +14% | +$1.92M |
|
158
Vera Therapeutics
VERA
$1.54B
| $16M | 0.02% |
66,572
+7,568
| +13% | +$1.82M |
|
159
Visa
V
$666B
| $15.8M | 0.02% |
4,521
-689
| -13% | -$2.41M |
|
160
KB Financial Group
KB
$28.5B
| $14.9M | 0.02% |
27,458
-8,130
| -23% | -$4.4M |
|
161
Schlumberger
SLB
$53.4B
| $14.3M | 0.02% |
34,100
-3,599
| -10% | -$1.5M |
|
162
Walt Disney
DIS
$212B
| $12.2M | 0.02% |
12,336
-30,680
| -71% | -$30.3M |
|
163
Infosys
INFY
$67.9B
| $10.8M | 0.02% |
59,072
-20,374
| -26% | -$3.72M |
|
164
POSCO
PKX
$15.5B
| $9.89M | 0.01% |
20,804
+5,442
| +35% | +$2.59M |
|
165
Zoetis
ZTS
$67.9B
| $9.58M | 0.01% |
5,816
-310
| -5% | -$510K |
|
166
Itaú Unibanco
ITUB
$76.6B
| $9.45M | 0.01% |
171,850
+2,512
| +1% | +$138K |
|
167
Dr. Reddy's Laboratories
RDY
$11.9B
| $9.37M | 0.01% |
71,001
+1,250
| +2% | +$165K |
|
168
MakeMyTrip
MMYT
$9.56B
| $8.5M | 0.01% |
8,674
-5,984
| -41% | -$5.86M |
|
169
Qualcomm
QCOM
$172B
| $8.45M | 0.01% |
5,501
+238
| +5% | +$366K |
|
170
Tenaris
TS
$18.2B
| $8.24M | 0.01% |
21,063
| – | – |
|
171
Grab
GRAB
$21B
| $8.15M | 0.01% |
179,976
-139,858
| -44% | -$6.34M |
|
172
Apple
AAPL
$3.56T
| $6.89M | 0.01% |
3,103
-1,145
| -27% | -$2.54M |
|
173
ASE Group
ASX
$22.8B
| $6.69M | 0.01% |
76,420
-2,943
| -4% | -$258K |
|
174
Sarepta Therapeutics
SRPT
$1.96B
| $6.04M | 0.01% |
9,458
-29,526
| -76% | -$18.8M |
|
175
Novartis
NVS
$251B
| $5.45M | 0.01% |
4,889
-2,911
| -37% | -$3.25M |
|